Urtishak K et al.’s study described multiple death mechanisms, including necroptosis, of obatoclax in killing infant ALL primary cells with MLL translocations that confer chemotherapy resistance [151]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.